News

News

March 4, 2020
DBV Technologies Reports Full-Year 2019 Financial Results and Provides Business Update
March 4, 2020
DBV Technologies Announces Closing of Underwriters’ Option to Purchase Additional Ordinary Shares in the Form of American Depositary Shares in Connection With its Global Offering
March 2, 2020
DBV Technologies Announces Partial Exercise of Underwriters’ Option to Purchase Additional Shares in Connection With its Global Offering of Ordinary Shares in the Form of American Depositary Shares (ADSs)
February 24, 2020
DBV Technologies to Present Detailed Safety and Efficacy Data of Viaskin Peanut at AAAAI 2020
February 21, 2020
DBV Technologies Announces FDA Advisory Committee Meeting to Review Viaskin Peanut for the Treatment of Peanut Allergy in Children
February 10, 2020
DBV Technologies to Present at the SVB Leerink 9th Annual Global Healthcare Conference
February 6, 2020
DBV Technologies Announces Appointment of Pascal Wotling as Chief Technical Operations Officer
February 4, 2020
DBV Technologies Announces Closing of Global Offering
January 30, 2020
DBV Technologies Announces Pricing of $153.7 million (€139.8 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares
January 29, 2020
DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares, and Reports December 31, 2019 Cash Position
Investor Relations Contact
Jonathan Neely

jonathan.neely@dbv-technologies.com

Media Contact
Brett Whelan
brett.whelan@dbv-technologies.com
Subscribe to get the latest DBV press releases
Subscribe
Scroll to Top